BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3977935)

  • 1. Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1985 Mar; 127(2):517-25. PubMed ID: 3977935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified human erythrocyte uroporphyrinogen decarboxylase and its amplification by iron.
    Mukerji SK; Pimstone NR; Tan KT
    FEBS Lett; 1985 Sep; 189(2):217-20. PubMed ID: 4043380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1988 Jul; 154(1):39-46. PubMed ID: 3395340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assay of uroporphyrinogen decarboxylase in erythrocytes.
    McManus J; Blake D; Ratnaike S
    Clin Chem; 1988 Nov; 34(11):2355-7. PubMed ID: 3180434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of familial porphyria cutanea tarda.
    Roberts AG; Elder GH; Newcombe RG; Enriquez de Salamanca R; Munoz JJ
    J Med Genet; 1988 Oct; 25(10):669-76. PubMed ID: 3225822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.
    Elder GH; Sheppard DM; Tovey JA; Urquhart AJ
    Lancet; 1983 Jun; 1(8337):1301-4. PubMed ID: 6134095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
    Elder GH; Sheppard DM; De Salamanca RE; Olmos A
    Clin Sci (Lond); 1980 Jun; 58(6):477-84. PubMed ID: 7428280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Decreased erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda].
    Kondo M
    Nihon Hifuka Gakkai Zasshi; 1985 Aug; 95(9):995-6. PubMed ID: 4079084
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrocyte uroporphyrinogen decarboxylase activity in 80 unrelated patients with porphyria cutanea tarda.
    Kószó F; Morvay M; Dobozy A; Simon N
    Br J Dermatol; 1992 May; 126(5):446-9. PubMed ID: 1610684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tarda.
    Sassa S; de Verneuil H; Anderson KE; Kappas A
    Trans Assoc Am Physicians; 1983; 96():65-75. PubMed ID: 6437037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients.
    Held JL; Sassa S; Kappas A; Harber LC
    J Invest Dermatol; 1989 Sep; 93(3):332-4. PubMed ID: 2768832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule?
    D'Alessandro Gandolfo L; Griso D; Macri A; Biolcati G; Topi GC
    Dermatologica; 1989; 178(4):206-8. PubMed ID: 2767288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some kinetic properties of human red cell uroporphyrinogen decarboxylase.
    de Verneuil H; Grandchamp B; Nordmann Y
    Biochim Biophys Acta; 1980 Jan; 611(1):174-86. PubMed ID: 7350915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte porphyrinogen carboxy-lyase activity in porphyria cutanea tarda and certain other human porphyrias.
    Ríos de Molina MC; Wainstok de Calmanovici R; Grinstein M; San Martín de Viale LC
    Clin Chim Acta; 1980 Dec; 108(3):447-56. PubMed ID: 7471475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.
    de Verneuil H; Beaumont C; Deybach JC; Nordmann Y; Sfar Z; Kastally R
    Am J Hum Genet; 1984 May; 36(3):613-22. PubMed ID: 6375356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
    Elder GH; Urquhart AJ; De Salamanca RE; Munoz JJ; Bonkovsky HL
    Lancet; 1985 Aug; 2(8449):229-33. PubMed ID: 2862415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uroporphyrinogen decarboxylase in erythrocytes: studies on the primary genetic enzyme defect in chronic hepatic porphyria (author's transl)].
    von Tiepermann R; Doss M
    J Clin Chem Clin Biochem; 1978 Sep; 16(9):513-7. PubMed ID: 712342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects.
    Elder GH; Roberts AG; de Salamanca RE
    Clin Biochem; 1989 Jun; 22(3):163-8. PubMed ID: 2786774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria.
    Felsher BF; Norris ME; Shih JC
    N Engl J Med; 1978 Nov; 299(20):1095-8. PubMed ID: 703786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyria cutanea tarda: erythrocyte uroporphyrinogen decarboxylase activity in 471 consecutive patients.
    Doss MO; Frank M; Braun-Falco O
    Curr Probl Dermatol; 1991; 20():97-105. PubMed ID: 1935224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.